CBIO insider trading
CIK 1253689CRESCENT BIOPHARMA, INC.: insider trade history from SEC Form 4 filings.
CBIO insider activity at a glance
FilingIQ tracks 183 insider transactions for CBIO in filings since Aug 20, 2015. The most recent transaction is dated Sep 18, 2026. They were reported by 30 insiders.
Across the full history, 25 open-market purchases
and 33 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest CBIO Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Tickers with similar insider activity
Ranked next to CBIO by Form 4 lines in the last 90 days, the number on each card.
Most active insiders at CBIO
By number of Form 4 lines in the last 180 days.
13F funds holding CBIO
For the quarter ended Sep 30, 2026, 106 institutional managers reported a CBIO position on SEC Form 13F.
Frequently asked
- How many insider trades does FilingIQ track for CBIO?
- FilingIQ tracks 183 Form 4 insider transactions for CBIO (CRESCENT BIOPHARMA, INC.), covering filings from Aug 20, 2015 onwards. 9 of those are dated within the last 90 days.
- Are CBIO insiders net buyers or net sellers?
- Across the full Form 4 history for CBIO, 25 transactions (14%) were open-market purchases and 33 (18%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does CBIO insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
- How many institutions report holding CBIO?
- For the quarter ended Sep 30, 2026, 106 institutional managers reported a CBIO position on SEC Form 13F. Investment managers with discretion over $100 million or more in 13(f) securities, mostly US-listed stocks, file a Form 13F within 45 days of each quarter end.
Methodology & sources
Every CBIO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Institutional holder counts come from the quarter's SEC Form 13F reports. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.